Literature DB >> 16182347

Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix.

Mildred R Chernofsky1, Juan C Felix, Laila I Muderspach, C Paul Morrow, Wei Ye, Susan G Groshen, Lynda D Roman.   

Abstract

OBJECTIVE: To determine if the quantity of lymph vascular space invasion (LVSI) correlates with time to recurrence in women with early-stage squamous carcinoma of the cervix.
METHODS: 101 consecutive women with Stages IA2, IB, and IIA squamous carcinoma of the cervix who had undergone radical hysterectomy between 1991 and 1997, with previously reported histopathologic quantification of LVSI by four methods, were prospectively followed. The outcome measure was time to recurrence. Univariate and stratified log-rank test analysis was performed to test the association of time to recurrence with prognostic factors. Further analysis was focused on recurrence in those patients who had negative surgical margins and whose tumors contained LVSI, incorporating the four quantification measures.
RESULTS: Nineteen (19%) women had cancer recurrence. The presence of LVSI (P = 0.05), cervical stromal invasion (P = 0.01), parametrial involvement (P < 0.001), and positive margins (P < 0.0001) were significantly related to time to recurrence on univariate analysis. In patients whose tumors had negative surgical margins and contained LVSI (65%), percentage of all sections with LVSI >29% and total number of foci with LVSI >5 were significantly related to time to recurrence (P = 0.006). When stratifying for cervical stromal invasion, lymph node status, and parametrial involvement in this group, percentage of all sections with LVSI >29% and total number of foci with LVSI >5 were significantly related to time to recurrence (P = 0.05).
CONCLUSION: The quantity of LVSI, as defined by the percentage of all sections with LVSI and total number of foci with LVSI, is an independent prognostic factor for time to recurrence in women with early-stage squamous carcinoma of the cervix.

Entities:  

Mesh:

Year:  2005        PMID: 16182347     DOI: 10.1016/j.ygyno.2005.08.019

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

Review 1.  The role of imaging in the management of non-metastatic cervical cancer.

Authors:  Orit Kaidar-Person; Roxolyana Bortnyak-Abdah; Amnon Amit; Alison Berniger; Rahamim Ben-Yosef; Abraham Kuten
Journal:  Med Oncol       Date:  2012-04-25       Impact factor: 3.064

2.  Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.

Authors:  Mika Okazawa-Sakai; Takanori Yokoyama; Etsuko Fujimoto; Shinichi Okame; Yuko Shiroyama; Takashi Yokoyama; Kazuhiro Takehara
Journal:  Int J Clin Oncol       Date:  2018-02-14       Impact factor: 3.402

Review 3.  A case of bilateral pelvic lymph node involvement in stage 1a1 squamous cell carcinoma of cervix and a review of the literature.

Authors:  Shamima Yeasmin; Kentaro Nakayama; Masako Ishikawa; Naomi Nakayama; Kohji Miyazaki
Journal:  Int J Clin Oncol       Date:  2009-12-05       Impact factor: 3.402

4.  Conservative treatment in early cervical cancer.

Authors:  Mojgan Karimi-Zarchi; Azamsadat Mousavi; Mitra Modares Gilani; Esmat Barooti; Ashrafosadat Miratashi-Yazdi; Atefe Dehghani
Journal:  Int J Biomed Sci       Date:  2013-09

5.  Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative intensity modulated radiotherapy for early-stage cervical cancer.

Authors:  Zhongjie Chen; Li Zhu; Bailin Zhang; Maobin Meng; Zhiyong Yuan; Ping Wang
Journal:  BMC Cancer       Date:  2014-10-29       Impact factor: 4.430

6.  Stomatin-like protein 2 is overexpressed in cervical cancer and involved in tumor cell apoptosis.

Authors:  Huan Deng; Yongjian Deng; Feiye Liu; Jie Chen; Zheng Li; Kelei Zhao; Xiaoqian Guan; Weijiang Liang
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

7.  Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer.

Authors:  Rise Miyauchi; Yoshiyuki Itoh; Mariko Kawamura; Akihiro Hirakawa; Kiyosumi Shibata; Hiroaki Kajiyama; Rie Nakahara; Seiji Kubota; Junji Ito; Tohru Okada; Fumitaka Kikkawa; Shinji Naganawa
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

8.  Prognostic value of lymphovascular space invasion in patients with early stage cervical cancer in Jilin, China: A retrospective study.

Authors:  Wenxing Yan; Shuang Qiu; Yaming Ding; Qi Zhang; Lihui Si; Sha Lv; Linlin Liu
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

9.  Clinical Implication of Simultaneous Intensity-modulated Radiotherapy Boost to Tumor Bed for Cervical Cancer with Full-thickness Stromal Invasion.

Authors:  Zongkai Zhang; Long Jiang; Rui Bi; Xiaohua Wu; Jun Zhu; Guihao Ke
Journal:  Oncologist       Date:  2022-02-03

10.  Significance of lymphovascular space invasion in epithelial ovarian cancer.

Authors:  Koji Matsuo; Todd B Sheridan; Kiyoshi Yoshino; Takahito Miyake; Karina E Hew; Dwight D Im; Neil B Rosenshein; Seiji Mabuchi; Takayuki Enomoto; Tadashi Kimura; Anil K Sood; Lynda D Roman
Journal:  Cancer Med       Date:  2012-09-14       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.